Bard Associates Inc. Has $1.24 Million Stock Holdings in Utah Medical Products, Inc. (NASDAQ:UTMD)

Bard Associates Inc. grew its position in Utah Medical Products, Inc. (NASDAQ:UTMD) by 1.3% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 20,030 shares of the medical instruments supplier’s stock after purchasing an additional 249 shares during the period. Bard Associates Inc. owned about 0.59% of Utah Medical Products worth $1,237,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in UTMD. Golden State Wealth Management LLC acquired a new stake in shares of Utah Medical Products in the 4th quarter valued at $31,000. R Squared Ltd acquired a new stake in shares of Utah Medical Products in the 4th quarter valued at $49,000. BNP Paribas Financial Markets boosted its stake in shares of Utah Medical Products by 102.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 1,117 shares of the medical instruments supplier’s stock valued at $75,000 after purchasing an additional 566 shares in the last quarter. SG Americas Securities LLC acquired a new stake in shares of Utah Medical Products in the 4th quarter valued at $157,000. Finally, Virtu Financial LLC acquired a new position in Utah Medical Products during the 3rd quarter worth about $207,000. Institutional investors and hedge funds own 69.60% of the company’s stock.

Utah Medical Products Stock Down 0.6 %

Shares of NASDAQ UTMD opened at $59.23 on Tuesday. The firm’s 50-day simple moving average is $61.16 and its 200 day simple moving average is $64.11. The company has a market cap of $200.91 million, a price-to-earnings ratio of 14.99 and a beta of 0.08. Utah Medical Products, Inc. has a 12-month low of $58.87 and a 12-month high of $77.33.

Utah Medical Products (NASDAQ:UTMD) last issued its quarterly earnings results on Tuesday, January 28th. The medical instruments supplier reported $0.86 earnings per share (EPS) for the quarter. Utah Medical Products had a net margin of 33.92% and a return on equity of 11.07%.

Utah Medical Products Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, April 3rd. Shareholders of record on Friday, March 14th will be given a dividend of $0.305 per share. The ex-dividend date of this dividend is Friday, March 14th. This represents a $1.22 dividend on an annualized basis and a yield of 2.06%. Utah Medical Products’s payout ratio is presently 30.89%.

Wall Street Analyst Weigh In

Separately, StockNews.com downgraded shares of Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research report on Thursday, November 7th.

About Utah Medical Products

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.